Concert Pharmaceuticals Announces Pricing of Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St indexes fall to two-week lows as rising bond yields, disappointing Walmart results drag
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Concert Pharma (CNCE) Prices 3.3M Common Stock Offering at $15.15/Share
March 19, 2015 9:24 AM EDTConcert Pharma (NASDAQ: CNCE) announced the pricing of an underwritten public offering of 3,300,000 shares of its common stock at a public offering price of $15.15 per share.
All shares in the offering are being sold by Concert, with expected net proceeds to Concert of approximately $46.7... More
